Nationwide Fund Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-71,609
| Closed | -$3.48M | – | 2416 |
|
|
2017
Q3 | $3.48M | Buy |
71,609
+10,382
| +17% | +$505K | 0.01% | 1185 |
|
|
2017
Q2 | $3.22M | Buy |
61,227
+9,104
| +17% | +$478K | 0.01% | 1225 |
|
|
2017
Q1 | $2.36M | Sell |
52,123
-3,530
| -6% | -$160K | 0.01% | 1326 |
|
|
2016
Q4 | $2.11M | Sell |
55,653
-5,500
| -9% | -$208K | 0.01% | 1386 |
|
|
2016
Q3 | $2.31M | Sell |
61,153
-18,320
| -23% | -$691K | 0.01% | 1319 |
|
|
2016
Q2 | $1.4M | Buy |
79,473
+2,490
| +3% | +$43.8K | 0.01% | 1535 |
|
|
2016
Q1 | $936K | Buy |
76,983
+20,905
| +37% | +$254K | ﹤0.01% | 1758 |
|
|
2015
Q4 | $1.37M | Buy |
56,078
+20,265
| +57% | +$493K | 0.01% | 1559 |
|
|
2015
Q3 | $635K | Hold |
35,813
| – | – | ﹤0.01% | 1964 |
|
|
2015
Q2 | $632K | Buy |
35,813
+5,574
| +18% | +$98.4K | ﹤0.01% | 2119 |
|
|
2015
Q1 | $948K | Sell |
30,239
-212
| -0.7% | -$6.65K | ﹤0.01% | 1913 |
|
|
2014
Q4 | $889K | Sell |
30,451
-73
| -0.2% | -$2.13K | ﹤0.01% | 1869 |
|
|
2014
Q3 | $632K | Buy |
30,524
+3,238
| +12% | +$67K | ﹤0.01% | 2070 |
|
|
2014
Q2 | $676K | Buy |
27,286
+2,093
| +8% | +$51.9K | ﹤0.01% | 2094 |
|
|
2014
Q1 | $534K | Buy |
25,193
+19,398
| +335% | +$411K | ﹤0.01% | 2032 |
|
|
2013
Q4 | $104K | Buy |
+5,795
| New | +$104K | ﹤0.01% | 2942 |
|